The aforementioned network pharmacology of CFD shows that CFD could regulate the IR and PI3K/Akt pathway for PCOS treatment, which suggested that the therapy effect of CFD in PCOS was related to the improvement of IR and might be via the PI3K/Akt pathway [18]. The gene discussed is AKT1; the disease is polycystic ovary syndrome.